LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

miRNA Extracted from FFPE Tissues Will Aid Cancer Prognosis

By LabMedica International staff writers
Posted on 03 Sep 2009
MicroRNAs (miRNAs) were extracted from formalin-fixed paraffin-embedded (FFPE) cancer tissues using a new, optimized protocol.

The new method for extracting miRNAs from FFPE tissues enabled scientists to identify 17 new and 53 known miRNAs from normal skin, melanoma, and sentinel lymph nodes. The miRNAs were well preserved in a 10-year-old specimen. Identification of novel miRNAs that differ in cancerous and healthy tissue, even from long-preserved tissue, will lead to better predictions of disease prognosis and treatment response.

Cancer tissues from patients are frequently stored by a method involving formalin fixation and paraffin embedding to retain morphological definition for identification. This method frequently prevents further molecular analysis of the tissue because of messenger RNA (mRNA) degradation. However, the tissues contain high numbers of microRNAs (miRNAs), which are short enough--approximately 22 nucleotides long--not to be broken down during the fixation process.

Dr. Soheil Dadras and colleagues from the Stanford University School of Medicine (Stanford, CA, USA) developed the new protocol for miRNA extraction. They reported the study in the September 2009 issue of the Journal of Molecular Diagnostics. The authors wrote that their "cloning strategy has the advantage of not only discovering novel and known miRNA sequence identity but also providing an estimate of relative expression level."

Related Links:
Stanford University School of Medicine




New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Collection and Transport System
PurSafe Plus®
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
New
Capillary Blood Collection Tube
IMPROMINI M3

Latest Molecular Diagnostics News

2-Hour Cancer Blood Test to Transform Tumor Detection
03 Sep 2009  |   Molecular Diagnostics

Ultrasensitive Test Could Identify Earliest Molecular Signs of Metastatic Relapse in Breast Cancer Patients
03 Sep 2009  |   Molecular Diagnostics

Automated High Throughput Immunoassay Test to Advance Neurodegenerative Clinical Research
03 Sep 2009  |   Molecular Diagnostics